tau alzheimer| What is tau alzheimer|Papers on tau alzheimer |Research on tau alzheimer | Publications on tau alzheimer

1.

BETA-AMYLOID CARRYING THE DUTCH MUTATION HAS DIVERSE EFFECTS ON CALPAIN-MEDIATED TOXICITY IN HIPPOCAMPAL NEURONS.

Nicholson AM, Wold LA, Walsh DM, Ferreira A.

Mol Med. 2011 Dec 1. doi: 10.2119/molmed.2011.00366. [Epub ahead of print]

PMID:

22160219

[PubMed - as supplied by publisher]

Related citations

2.

Cerebrospinal Fluid Proteins Predict Longitudinal Hippocampal Degeneration in Early-stage Dementia of theAlzheimer Type.

Wang L, Fagan AM, Shah AR, Beg MF, Csernansky JG, Morris JC, Holtzman DM.

Alzheimer Dis Assoc Disord. 2011 Dec 7. [Epub ahead of print]

PMID:

22156755

[PubMed - as supplied by publisher]

Related citations

3.

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia.

Spitzer P, Schieb H, Kamrowski-Kruck H, Otto M, Chiasserini D, Parnetti L, Herukka SK, Schuchhardt J, Wiltfang J, Klafki HW.

Int J Alzheimers Dis. 2011;2011:739847. Epub 2011 Nov 24.

PMID:

22145083

[PubMed - in process]

Free PMC Article

Related citations

4.

Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development.

Nordberg A.

Alzheimers Res Ther. 2011 Dec 2;3(6):34. [Epub ahead of print]

PMID:

22136152

[PubMed - as supplied by publisher]

Related citations

5.

Interaction between α-Synuclein and Other Proteins in Neurodegenerative Disorders.

Jellinger KA.

ScientificWorldJournal. 2011;11:1893-907. Epub 2011 Oct 24.

PMID:

22125446

[PubMed - in process]

Free PMC Article

Related citations

6.

Long-term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AβPP and AβPP/tautransgenic mice.

Akiyama H, Hosokawa M, Kametani F, Kondo H, Chiba M, Fukushima M, Tabira T.

Neuropathology. 2011 Nov 28. doi: 10.1111/j.1440-1789.2011.01274.x. [Epub ahead of print]

PMID:

22118300

[PubMed - as supplied by publisher]

Related citations

7.

Insights into Mitochondrial Dysfunction: Aging, Amyloid-β and Tau - a deleterious trio.

Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Götz J, Eckert A.

Antioxid Redox Signal. 2011 Nov 27. [Epub ahead of print]

PMID:

22117646

[PubMed - as supplied by publisher]

Related citations

8.

(Val(8)) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.

Li L, Zhang ZF, Holscher C, Gao C, Jiang YH, Liu YZ.

Eur J Pharmacol. 2011 Nov 12. [Epub ahead of print]

PMID:

22115895

[PubMed - as supplied by publisher]

Related citations

9.

Alzheimer disease biomarkers are associated with body mass index.

Vidoni ED, Townley RA, Honea RA, Burns JM; For the Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2011 Nov 22;77(21):1913-1920.

PMID:

22105948

[PubMed - as supplied by publisher]

Related citations

10.

Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B.

Ohmi K, Zhao HZ, Neufeld EF.

PLoS One. 2011;6(11):e27461. Epub 2011 Nov 9.

PMID:

22096577

[PubMed - in process]

Free PMC Article

Related citations

11.

Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1.

Platt B, Drever B, Koss D, Stoppelkamp S, Jyoti A, Plano A, Utan A, Merrick G, Ryan D, Melis V, Wan H, Mingarelli M, Porcu E, Scrocchi L, Welch A, Riedel G.

PLoS One. 2011;6(11):e27068. Epub 2011 Nov 11.

PMID:

22096518

[PubMed - in process]

Free PMC Article

Related citations

12.

Cell Cycle Proteins in Brain in Mild Cognitive Impairment: Insights into Progression to Alzheimer Disease.

Keeney JT, Swomley AM, Harris JL, Fiorini A, Mitov MI, Perluigi M, Sultana R, Butterfield DA.

Neurotox Res. 2011 Nov 15. [Epub ahead of print]

PMID:

22083458

[PubMed - as supplied by publisher]

Related citations

13.

CSF biomarkers in different phenotypes of Parkinson disease.

Jellinger KA.

J Neural Transm. 2011 Nov 8. [Epub ahead of print]

PMID:

22065209

[PubMed - as supplied by publisher]

Related citations

14.

Progression from Mild to Pronounced MCI Is Not Associated with Cerebrospinal Fluid Biomarker Deviations.

Wallin A, Göthlin M, Gustavsson M, Zetterberg H, Eckerström C, Blennow K, Edman A, Lind K, Nordlund A, Rolstad S.

Dement Geriatr Cogn Disord. 2011;32(3):193-7. Epub 2011 Nov 3.

PMID:

22057225

[PubMed - in process]

Related citations

15.

GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.

Santa-Maria I, Diaz-Ruiz C, Ksiezak-Reding H, Chen A, Ho L, Wang J, Pasinetti GM.

Neurobiol Aging. 2011 Nov 3. [Epub ahead of print]

PMID:

22054871

[PubMed - as supplied by publisher]

Related citations

16.

Challenges associated with curcumin therapy in Alzheimer disease.

Belkacemi A, Doggui S, Dao L, Ramassamy C.

Expert Rev Mol Med. 2011 Nov 4;13:e34.

PMID:

22051121

[PubMed - in process]

Related citations

17.

New pharmacological strategies for treatment of Alzheimer's disease: focus on disease-modifying drugs.

Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F.

Br J Clin Pharmacol. 2011 Oct 28. doi: 10.1111/j.1365-2125.2011.04134.x. [Epub ahead of print]

PMID:

22035455

[PubMed - as supplied by publisher]

Related citations

18.

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Jucker M, Walker LC.

Ann Neurol. 2011 Oct;70(4):532-40. doi: 10.1002/ana.22615.

PMID:

22028219

[PubMed - in process]

Related citations

19.

Cerebrolysin in Alzheimer's disease.

Antón Álvarez X, Fuentes P.

Drugs Today (Barc). 2011 Jul;47(7):487-513.

PMID:

22013558

[PubMed - indexed for MEDLINE]

Related citations

20.

Truncation of tau at E391 promotes early pathologic changes in transgenic mice.

McMillan PJ, Kraemer BC, Robinson L, Leverenz JB, Raskind M, Schellenberg G.

J Neuropathol Exp Neurol. 2011 Nov;70(11):1006-19. doi: 10.1097/NEN.0b013e31823557fb.

PMID:

22002427

[PubMed - indexed for MEDLINE]